SLNO
SOLENO THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$53.01
+0.00%Sep 8, 2026, 11:11 UTC
Kura Oncology, Inc. appointed Jennifer Fulk as Chief Financial Officer, effective September 8, 2026.
Jun 30, 2026, 00:00 UTC
Matthew Pauls was appointed as a Class I director of Palvella Therapeutics, Inc.